Effects of Mineralocorticoid Receptor Antagonist Spironolactone on Atrial Conduction and Remodeling in Patients With Heart Failure
Journal of Cardiology - Japan
doi 10.1016/j.jjcc.2010.11.006
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2011
Authors
Publisher
Elsevier BV